Retest of co's baby shampoo shows absence of formaldehyde: J&J

Image
Press Trust of India New Delhi
Last Updated : Jun 10 2019 | 2:00 PM IST

Johnson & Johnson Monday said safety of its baby shampoo has been reaffirmed by the Central Drugs Standard Control Organisation's laboratories which have confirmed that the product does not contain formaldehyde -- which can cause cancer.

On March 5, 2019, the Rajasthan Drugs Control Organization had reported presence of formaldehyde in samples of two batches of Johnson's baby shampoo manufactured by Johnson & Johnson in India.

The company had rejected the finding and had said its products do not contain formaldehyde or any ingredient capable of releasing formaldehyde. It had questioned the Rajasthan drug controller's claim as well as the method of testing that led to the test results.

Since J&J challenged the finding, the shampoo was sent to Central Drugs Standard Control Organisation's (CDSCO's) laboratories for re-testing, the company said in a statement.

The Rajasthan FDA on their website has posted a report "that concluded the investigation and said that, showing re-testing results of samples by the appellate laboratory confirming that Johnson's Baby shampoo does not contain formaldehyde," it added.

The report release came after several weeks of testing at the central government laboratory after samples were picked up in India to test for presence of any harmful ingredients, the statement said.

"We are pleased with the conclusion of the Rajasthan FDA, which confirms that Johnson's Baby Shampoo does not contain formaldehyde," a Johnson & Johnson spokesperson told PTI.

This outcome reaffirms company's own testing and the longstanding assurance it gave that its baby shampoo does not contain formaldehyde or any formaldehyde-releasing ingredients, she added.

"Importantly, this is the result of the appellate laboratory, following a magistrate court order for re-testing, and overrules an earlier test result that was erroneous," the spokesperson said.

Nothing is more important to Johnson & Johnson than the safety of the people who use its products, and the company's quality assurance process is rigorous meeting or exceeding standards in every country where its products are sold, she added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 10 2019 | 2:00 PM IST

Next Story